genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2015
Nausea
News
Acute Morning Sickness Linked to Developmental Disorders in Children
Cancer
Galena Licenses U.S. Rights to Zuplenz Oral Film for $5M+
News
Endo Acquiring NuPathe for $105M+
News
FDA Approves Takeda-Lundbeck Drug for Major Depressive Disorder
News
Sucampo Reports Positive Phase III Results in Opioid-Induced Bowel Dysfunction
Cancer
Eisai Gains U.S. Commercialization Rights to Helsinn’s Combination Antiemetic
Cancer
FDA Not Ready to Approve A.P. Pharma’s Treatment for Chemotherapy-Induced Nausea and Vomiting
Insights
Savara Breathes Life into Inhaled Therapeutics
Cancer
A.P. Pharma Eliminates Another 11 Positions
News
Eisai Snags MGI Pharma for $3.9B
1
2
3
Page 2 of 3
Scroll Up
Scroll Up
